TERMS & CONDITIONS: purchasing membership with SFTCG
Members must be 18 years old or older.
Applications for membership are received by the Society in good faith. Each application and any related membership subscription will be acknowledged by the Society on completion of the online process.
Membership benefits are available as soon as membership registration and payment has taken place.
Society members benefit from a lower fee to the SFTCG Congress. An active and paid membership must be in place in order to be able to register to the Congress at the lower member congress rate.
SFTCG membership runs on a calendar year, ie 1st January – 31st December. Membership lasts from the day it is taken out until the 31st December, regardless of date of purchase.
Usually, refunds are not given; requests can be sent to email@example.com.
Membership fees and benefits are subject to change at no notice, and can be viewed on the membership page. By agreeing to these Terms & Conditions, you agree to the membership benefits as outlined on the membership page.
Your membership purchase and payment will be acknowledged by an automated emailed to the email address in your profile. Your invoice will be attached to the membership confirmation email.
Members are invited to attend the AGM during the SFTCG Congress. During this AGM members will be allowed to vote on society issues raised during the AGM.
Members are also eligible to stand for election to the Board; elections are scheduled as announced in society emails.
The SFTCG partners with Human Gene Therapy Journals and they may on some occasion publish the congress abstracts. Please note that as part of your SFTCG membership and acceptance of these conditions, you agree to your data to be shared with Human Gene Therapy. Please note they will not be using your details for marketing purposes but may contact you by email to opt in to receiving such emails, which you may decline or accept.
Please note that Human Gene Therapy is based in the US, which requires us to transfer your profile data outside of the EU without the adequate protections in place as stipulated by EU data protection regulations. In this instance;
Human Gene Therapy agrees to SFTCG’s requirements regarding data protection
No unnecessary data will be shared
Data will be transferred securely.